Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3030-3033

  Egermann, U ^a   Stanga, Z ^a   Ramin, A ^c   Acosta, F ^a   Stucki, A ^a   Gerber, P ^a   Cottagnoud, M ^b   Cottagnoud, P ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Clinic of Internal Medicine   (Switzerland)

^c Klinik Sonnenhof   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DAPTOMYCIN; DEXAMETHASONE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG PENETRATION; EXPERIMENTAL INFECTION; LISTERIA MONOCYTOGENES; MONOTHERAPY; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPTOMYCIN; DEXAMETHASONE; DRUG THERAPY, COMBINATION; MENINGITIS, BACTERIAL; RABBITS; VANCOMYCIN;

EID: 67649960173     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00952-08     Document Type: Article

References (15)

1. Aronin, S. I., P. Peduzzi, and V. J. Quagliarello. 1998. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann. Intern. Med. 129:862-869.
2. Cottagnoud, P. 2008. Daptomycin: a new treatment for insidious infections due to gram-positive pathogens. Swiss Med. Wkly. 138:93-99.
3. Cottagnoud, P., M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H. P. Muller, and A. Stucki. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928-3933.
4. Dacey, R. G., and M. A. Sande. 1974. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6:437-441.
5. Doern, G. V., M. A. Pfaller, K. Kugler, J. Freeman, and R. N. Jones. 1998. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27:764-770.
6. Gerber, P., A. Stucki, F. Acosta, M. Cottagnoud, and P. Cottagnoud. 2006. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J. Antimicrob. Chemother. 57:720-723.
7. Grandgirard, D., C. Schurch, P. Cottagnoud, and S. L. Leib. 2007. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob. Agents Chemother. 51:2173-2178.
8. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S81-S93.
9. Johnson, D. M., M. G. Stilwell, T. R. Fritsche, and R. N. Jones. 2006. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn. Microbiol. Infect. Dis. 56:69-74.
10. Martinez-Lacasa, J., C. Cabellos, A. Martos, A. Fernandez, F. Tubau, P. F. Viladrich, J. Linares, and F. Gudiol. 2002. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J. Antimicrob. Chemother. 49:507-513.
11. McMillan, D. A., C. Y. Lin, S. I. Aronin, and V. J. Quagliarello. 2001. Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin. Infect. Dis. 33:969-975.
12. París, M. M., S. M. Hickey, M. I. Uscher, S. Shelton, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 38:1320-1324.
13. París, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
14. Quagliarello, V. J., and W. M. Scheld. 1997. Treatment of bacterial meningitis. N. Engl. J. Med. 336:708-716.
15. 3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrob. Agents Chemother. 51:2249-2252.